Results 121 to 130 of about 8,860 (153)
Some of the next articles are maybe not open access.
Annals of Pharmacotherapy, 2004
OBJECTIVE To review the pharmacology, virology, pharmacokinetics, resistance profile, clinical efficacy, safety, and drug interactions of atazanavir. DATA SOURCES A PubMed and NLMGateway search (1966–June 2004) utilizing the key words ...
Joanne J, Orrick, Corklin R, Steinhart
exaly +4 more sources
OBJECTIVE To review the pharmacology, virology, pharmacokinetics, resistance profile, clinical efficacy, safety, and drug interactions of atazanavir. DATA SOURCES A PubMed and NLMGateway search (1966–June 2004) utilizing the key words ...
Joanne J, Orrick, Corklin R, Steinhart
exaly +4 more sources
Drugs, 2003
Atazanavir is a novel azapeptide protease inhibitor with high specificity for, and activity against, HIV-1 protease. The resistance profile of atazanavir is distinct, with an I50 L protease substitution appearing to be the signature mutation. Atazanavir was not associated with increases in total cholesterol, low density lipoprotein-cholesterol or ...
David R, Goldsmith, Caroline M, Perry
+5 more sources
Atazanavir is a novel azapeptide protease inhibitor with high specificity for, and activity against, HIV-1 protease. The resistance profile of atazanavir is distinct, with an I50 L protease substitution appearing to be the signature mutation. Atazanavir was not associated with increases in total cholesterol, low density lipoprotein-cholesterol or ...
David R, Goldsmith, Caroline M, Perry
+5 more sources